NASDAQ:ANIK

Anika Therapeutics, Inc Earning Date

USA |NASDAQ |USD

ANIK Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 2, 2021 Sep 2021 $-0.21 $0.09 $0.05
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 2, 2021 Sep 2021 $36.65M $38.15M $31.69M

Anika Therapeutics, Inc's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 2021.

ANIK Earnings Date & History Chart

ANIK Earnings & Revenue Forecast

ANIK Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.15 $-0.36 $-0.04
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.27 $-0.14 $0.48
Dec 2022 3 $0.00 $-0.95 $0.75

ANIK Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.15 $0.00 $0.02
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.27 $-0.04 $0.05
Dec 2022 0 / 0 $0.00 $0.27 $0.50

ANIK Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $39.08M $37.75M $40.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $147.52M $146.64M $148.43M
Dec 2022 3 $169.07M $166.78M $172.52M

ANIK Earnings Date & Revenue History

ANIK Earnings History

|
Show More
Show More

ANIK Revenue History

|
Show More
Show More

Anika Therapeutics, Inc Next Earnings Date & Report

ANIK Next Earnings Date & Report Preview: Sep 2021 (FQ)

ANIK's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 3 analysts, the average EPS estimation for Anika Therapeutics, Inc's next quarterly earnings is $-0.21, with a low EPS estimation of $-0.42, and a high estimation of $-0.09.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.21, the last 2 month trend is $-0.08, and the 3 month trend is $-0.05.

Based on 3 analysts, the average revenue estimation is $36.65M, with a low revenue estimation of $36.45M, and a high estimation of $37.00M.

Anika Therapeutics, Inc Previous Earnings Dates & Reports

ANIK Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Anika Therapeutics, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

ANIK's earnings per share (EPS) was $0.09, beating the consensus analysts forecast of $-0.03 by 434.57%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 50.00%, and higher than the same period a year before (Jun 2020) by 0.00%.

Revenues were $38.15M, better than the forecast of $38.15M by 0.00%, up by 11.24% from the previous quarter , and up by 24.34% from the same period last year.

The company reported a net income of $6.53M.

Free cash flow for the quarter was $-869.00K , compared to $-2.85M last quarter and $3.38M a year before.

ANIK Previous Earnings Date & Report Recap: Dec 2020 (FY)

Anika Therapeutics, Inc's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.

ANIK's earnings per share (EPS) was $0.71, beating the consensus analysts forecast of $-0.51 by -239.22% , and lower than the previous year's EPS (Dec 2019) by -65.37%.

Revenues were $130.46M, worse than the forecast of $131.28M by -0.63%, and up by 13.83% from previous year's revenue.

The company reported a net income of $-23.98M.

Anika Therapeutics, Inc reported a free cash flow of $11.44M for its fiscal year, compared to $34.18M a year ago.

The company ended the fiscal year with $22.46M in total debt, a decrease of -0.20% compared to the previous year.